Tag Archives: Dallas’ Taysha Gene Therapies raises $157 million

Newly public Dallas-based biotech company Taysha Gene Therapies raised $157 million and saw a 20% rise in its stock price on its first day of trading. Shares for Taysha, an explosive new startup based in Dallas, began trading on Nasdaq Thursday morning after pricing its shares at $20. The company, trading under the TSHA ticker, closed at $24.06. The company …

Read More »